O ne of the strongest linkages known to date between the presence of an HLA allele and disease susceptibility is that of HLA-B27 to inflammatory spondyloarthropathies in humans (1) . Although it is clear that the presence of the HLA-B27 allele predisposes humans to the disease, its role in disease pathogenesis is unclear. Studies on genetic polymorphism suggest that B'2705 and B'2702 alleles predispose humans for disease development, while B'2703 is not associated (2) . Recent knowledge about the three-dimensional structure of the HLA-B27 molecule and peptide elution studies suggest that peptides approximately nine amino acids long with arginine at position 2 bind to HLA-B27 (3, 4) . Several hypotheses for the association of HLA-B27 with the human disease have been proposed, including (a) presentation of arthritogenic peptide by this MHC class I molecule, (b) molecular mimicry of HLA-B27 with certain microorganisms, (c) altered self, and (d) the possible role of closely linked genes (5) .
Transgenic rats expressing several copies of the HLA-B27 and the human 132-microglobulin genes develop a spontaneous inflammatory disease that has many similarities to human spondyloarthropathy (6) . We have previously demonstrated expression of the HLA-B27 gene in transgenic mice (7) . Until now, no arthritis, either spontaneous or induced, has been observed in these transgenic mice. To determine whether processing, assembly, transport, and expression of the HLA-B27 molecule may play a role in the disease process, we introduced the HLA-B27 transgene into the 132-microglobulin-deficient mice. Spontaneous arthritis was observed in HLA-B27 transgenic mice lacking 132-microglobulin (B27+132 m-/-) compared with B27+132m +/-full sibs. An environmental trigger for the development of disease is involved, since mice housed in the specific pathogen-free barrier colony are unaffected. Similar to HLA-B27-related human spondyloarthropathies, male animals were primarily affected. Our results suggest that aberrant assembly and/or expression of HLA-B27 may perturb the T cell repertoire and cause disease development.
Materials and Methods
Mice. The HLA-B27 (B'2705) transgenic mice used in this study have been described elsewhere (7) . Mutated ~2 m-/-mice were the kind gift of Dr. B. Koller (8) . HLA-B27-positive mice from (132 m-/-• HLA-B27)F 1 crosses were intercrossed to obtain B27+132m -/-animals. The presence of the HLA-B27 transgene in the F 2 population was identified by PCR using 3' (CTC TGC CTT GGC CTT GCA GA) and 5' (CCA CTC CAT GAG GTA TTT CCA) oligonucleotide sequences. The homozygous mutation in [32-microglobulin gene was identified as previously described by Koller et al. (8) . The B27+132m +/-full sibs, B27-[32 m+/-full sibs, and B27-[32 m-/-full sibs were used as controls. All the mice in our study were bred in the specific pathogen-free barrier facility.
Flow Cytometric Analysis. Analysis of expression of the HLA-B27 transgene was performed by flow cytometry. Isolated mononuclear cells from peripheral blood were incubated with either purified or biotinylated ME-1 (American Type Culture Collection, R.ockville, MD), HC10 (heavy chain specific; 9) or Ye-2 Cytotoxicity Assay. Target Con A blast of spleen cells were labeled with 150 vtCi SlCr (Amersham Corp., Arlington Heights, IL) for 90 min and placed at 1 )<104 per well in 96-well U -b o ttomed plates (Coming Inc., Coming, NY) in triplicates. Effector anti-B27 CTLs used in this study were the kind gift of Dr. Kaufman and Dr. Liebson (Mayo Clinic, Rochester, MN). These CTLs were generated from PBLs of a normal healthy individual by stimulating them with irradiated C1RB27 cells. Anti-CD14 mAb and rabbit complement were used to lyse possible N K cells. Effector cells (10 s) (10:1 E / T ratio) were added and incubated at 37~ for 4 h. The supematant was harvested and counted in a gamma counter (LKB Instruments Inc., Gaithersburg, MD). The percent specific 51Cr release was calculated as follows: % Cytolysis = (Sample -Spontaneous)/(Maximum -Spontaneous) • 100.
Quantification of Arthritis. The severity of arthritis was measured three times a week for a period of 6 mo as previously described (11) . Briefly, the severity of arthritis was measured on a scale of 0-3 for each paw (0, no arthritis; 1, mild inflammation in one or two fingers; 2, moderate inflammation in three or more fingers; and 3, ankylosis). Thus, the score for a single animal could vary from 0-12 depending on the severity of arthritis. . Cell-surface expression was also undetectable by using HC-10, Ye-2, and B27M1 mAb on PBLs from B27+I32m -/-animals (data not shown).
Results and Discussion
Generation of B27+ /32m -/-Mice. 
Spontaneous Inflammatory Disease in B27+~2 m-l-Mice.
The mice were healthy and normal as long as they stayed in our pathogen-free colony. Within 2 -4 wk after transfer to a conventional mouse colony, spontaneous development of nail and joint changes was observed in B27+[32m -/ -mice but not in B27 + ([~2 m + / -' +/+) or B27-([32nl +/-, -/ -) littermates. Clinical arthritis began with redness and swelling in a single toe of the rear paw. This progressed to involve both hind paws with swelling, deformity, and ankylosis (Fig. 3) . Nail changes were observed primarily in male mice at the onset of clinical arthritis (Fig. 4) . 33 of 44 (75%) male mice, 4 mo or older, developed spontaneous arthritis in comparison to 7 of the 23 (30%) female mice (Table 1) . Female mice developed milder arthritis with a delayed onset. About 40% of arthritic male animals showed ankylosis in at least one of their rear paws. The other mice developed a milder form of arthritis involving swelling in one or both rear paws. Front paws were unaffected in most of the diseased animals. These findings are similar to HLA-B27-related arthropathies in humans (12) . Histological changes in arthritic mice were characterized by synovial cell proliferation, cartilage and subchondral bone erosions, and m o n onuclear cell proliferation (Fig. 5) Aberrant processing of B27 H C s could also lead to dev e l o p m e n t of spontaneous arthritis in B27 +[32m -/ -mice or in rats with a high copy n u m b e r of B27 transgenes (16) . In the absence of [~2m or overexpression of the B27 gene, the class I molecules may be retained in the endoplasmic reticu l u m or cytoplasm. C o n t i n u o u s generation of such protein in the cytoplasm w o u l d lead to abnormal accumulation. T h e unassembled H C of H L A -B 2 7 may present extracellu- Figure 5 . Histology of the arthritic hind paw of the B27+[32m -/ mice 3 wk after transferring from the pathogen-free barrier facility to a conventional colony. Cellular proliferation in the synovium with exudation into the joint cavity are shown. The presence of pannus eroding the cartilage and subchondral bone is highlighted. Hematoxylin and eosin staining, 3<25 (A), X50 (B), and • (C).
Potential Mechanism for the Development of Disease.
T h e occurrence of spontaneous arthritis only in the B27+[32 m -/ -mice suggests several potential mechanisms in the disease process. W i t h few exceptions (13) , the H C of M H C class I molecules binds to [32m and peptides in the endoplasmic reticulum, and the trimeric complexes are transported to the cell surface (14) . lar peptides (17) or undergo normal protein degradation. Degraded products of HLA-B27 proteins may behave as an autoantigen and could be presented by the class II molecule to a CD4 + T cell. Exposure of these mice to environmental antigens with molecular mimicry could break self tolerance and may be the cause of disease development (18) . Even though normal expression of B27 is observed in patients, a defect in expression could have occurred during ontogeny or early childhood, causing positive selection of self-reactive T cells. Mutation in 132m (19) and polymorphism in peptide transporter (20, 21) or proteosome (22) genes could also result in selective peptide binding, inefficient processing and reduced transport of B27 molecules, and perturbation of T cell repertoire. Thus, abnormal processing, transport, and expression of HLA-B27 could predispose certain B27 § individuals to spondyloarthropathies.
To determine whether the HLA-B27 molecule may reach the cell surface in B27+[32m -/-mice, splenocytes were stimulated in vitro, and expression of free HCs of B27 was determined. Low-level expression of the HC of HLA-B27 was detected on the cell surface of Con A-stimulated splenocytes (Fig. 6 A) . The presence of HLA-B27 HCs on Con A-stimulated splenocytes was further confirmed when >50% lysis of B27+j32m -/-targets was seen with anti-HLA-B27 CTLs in a 51Cr release assay (Fig. 6 B) . The presence of HCs on the cell surface after stimulation suggests several scenarios: (a) Environmental antigens in the conventional colony may stimulate cells to express free HCs on the cell surface, (b) the presentation of extracellular peptide to residual CD8 + T cells, and (c) expansion of selfreactive T cells that could be autoreactive to self-MHC as shown in ~2m-deficient mice (15) . Studies are currently underway to determine the mechanism involved in the progression of disease in these mice.
In conclusion, our results clearly demonstrate a specific role for the B27 molecule in disease. It is obvious, though, that additional genetic factors and environmental triggers are required for the onset of autoimmunity. The occurrence of the disease in B27+[32m -/-mice suggests a possible role for aberrant expression of HLA-B27 in predisposing the mice to self reactivity. This mouse model opens several new avenues to further dissect the role of HLA-B27 in the disease process, since proteosome and transporter knockout animals are now available. Specificity of HLA-B27 association with this disease can be further tested by using other unrelated HLA class I transgenic mice (HLA-A3, HLA-B7) in the absence of [32m. We can also generate new transgenic mice with a non-disease-associated B'2703 or mutated B27 genes. In addition, a systematic analysis of the environmental agents involved in the disease trigger could pave the way for identification of the exogenous antigen and generation of vaccines and immunotherapeutic agents. We believe that rapid progress can be made in the understanding of the disease mechanism in HLA-B27-linked spondyloarthropathies using this mouse model.
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